Modified oligonucleotides as therapeutic and diagnostic agents

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Biotechnology

Background:

• Modified oligonucleotides are a novel class of therapeutic and diagnostic agents.
• Oligonucleoside phosphorothioates, hairpin structures, and chimeras are extensively studied analogs.
• Bio-reversible analogs and novel molecules like peptide nucleic acids are being developed.

Purpose of the Study:

• To explore the therapeutic and diagnostic potential of modified oligonucleotides and their analogs.
• To investigate novel oligonucleotide modifications for enhanced stability and function.
• To report on the development of bio-reversible analogs and other novel molecules.

Main Methods:

• Synthesis of modified oligonucleotides and their analogs.
• Investigation of structural modifications like hairpin structures and chimeras.
• Development of bio-reversible and neutral achiral backbone analogs.
• Characterization of peptide nucleic acids and circular oligonucleotides for duplex formation.
• Incorporation of fluorescent tags for diagnostic probe development.

Main Results:

• Several modified oligonucleotide analogs, including phosphorothioates, show therapeutic potential.
• Bio-reversible analogs have been synthesized to enhance oligonucleotide properties.
• Novel molecules like peptide nucleic acids and circular oligonucleotides form stable duplexes.
• Fluorescently tagged oligonucleotides are effective diagnostic probes.

Conclusions:

• Modified oligonucleotides and their analogs represent a significant advancement in therapeutic and diagnostic applications.
• Ongoing research focuses on enhancing stability, reversibility, and diverse functionalities.
• These molecules hold promise for future medical interventions and diagnostic tools.